search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
AN AGILE APPROACH


Going agile: how it can improve clinical trials


David Larwood, CEO of Valley Fever Solutions, discusses agile design.


adapt and redesign phases of a project. When it comes to clinical trials, agility can be incorporated into both the design and execution stages in order to refine and improve the process. Incrementally optimising a clinical trial like this increases its efficiency, meaning we can help more patients more quickly.


B


Agile design Agile design takes a complex project and breaks it down into relatively small components, fine-tuning each one for the benefit of the overall project. In clinical trials, numerous critical components can be optimised. The clinical endpoint is a measurement of some symptom or reading which is the target outcome of the trial – for example, the trial may aim to reduce the severity of a


8 | H1 Virtual Events: Review and Summary Handbook


y definition, agility is the ability to move quickly and easily. In project management terms, it means being able to frequently


certain symptom in subjects. This endpoint should be established in the trial design, along with the parameters of the trial and best practice procedures, which should be aligned across all test sites to avoid costly inconsistencies. Operations should be governed by a template protocol, and efficiency is maximised when the trial developers draw on previous experience, leveraging the perspective and expertise of the contract research organisation (CRO), the sponsor and the sites. Refining each of these details individually improves the overall trial. Operational agility can also be built in from the start. The goal of a clinical trial is to identify the right drug and the right dose to have to right effect, within constraints including safety, price and time. In a classic design, pre-clinical or comparative studies will suggest the endpoint, safety considerations, dose range and therapy windows. An agile clinical trial design builds in opportunities


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58